ERBB2 and breast carcinoma: Nonetheless, the tendency of higher levels of PC and Cho in the HER2-positive and luminal B subgroups of our ER-positive cancer samples is in accordance with those from recent metabolomics studies using CNB specimens or surgical tissue which found significant correlation between choline-containing metabolites in breast cancer tissue and the aggressive subgroups of breast cancer [18, 20].